Z-0879-2023 Class II Ongoing

Recalled by Detect Headquarters — Guilford, CT

FDA device recall Z-0879-2023 was initiated by Detect Headquarters on December 8, 2022 and is designated Class II. Reason for recall: There is an increased chance that the tests from affected lots may give false negative results. Health risks resulting from a false negative result include delay or lack of supportive treatment and la… The recall status is ongoing. Affected quantity: 10142 (US); 960 OUS.

Recall Details

Product Type
Devices
Report Date
January 11, 2023
Initiation Date
December 8, 2022
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10142 (US); 960 OUS

Product Description

Detect Covid-19 Test Product/Model Number: 21205

Reason for Recall

There is an increased chance that the tests from affected lots may give false negative results. Health risks resulting from a false negative result include delay or lack of supportive treatment and lack of monitoring of infected individuals and their household or other close contacts for symptoms resulting in increased risk of spread of COVID-19 within the community.

Distribution Pattern

Domestic distribution nationwide. Foreign distribution to Hong Kong.

Code Information

HY263, HY264, and HB264 Expiration 01JAN2023